Drug Designing: Open Access
Open Access

Department of Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Boston, USA

Publications

• Commentary   
  A Note on Bridging Study Design and Analysis
  Author(s): Mario Nagase*
  
  DOI: 10.35248/2169-0138.22.11.219

  HTML PDF